Baidu
map

2020 AISF临床实践指南:酒精性肝病

2020-01-27 意大利肝病学会 Dig Liver Dis. 2020 Jan 27.

2020年1月,意大利肝病学会(AISF)发布了酒精性肝病管理指南,酒精使用障碍是西方国家最常见的肝损伤的原因,其疾病范围广泛,包括脂肪变性,脂肪性肝炎,肝纤维化,肝硬化和肝癌。本文主要内容涉及酒精性肝病的流行病学,病理生理学,临床表现,诊断以及治疗的相关内容,主要目的是针对酒精性肝病的临床管理提供指导建议。

中文标题:

2020 AISF临床实践指南:酒精性肝病

英文标题:

Alcohol associated liver disease 2020: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF).

发布机构:

意大利肝病学会

发布日期:

2020-01-27

简要介绍:

2020年1月,意大利肝病学会(AISF)发布了酒精性肝病管理指南,酒精使用障碍是西方国家最常见的肝损伤的原因,其疾病范围广泛,包括脂肪变性,脂肪性肝炎,肝纤维化,肝硬化和肝癌。本文主要内容涉及酒精性肝病的流行病学,病理生理学,临床表现,诊断以及治疗的相关内容,主要目的是针对酒精性肝病的临床管理提供指导建议。

 

拓展指南:肝病相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2020 AISF临床实践指南:酒精性肝病)] GetToolGuiderByIdResponse(projectId=1, id=a167e1c001860591, title=2020 AISF临床实践指南:酒精性肝病, enTitle=Alcohol associated liver disease 2020: A clinical practice guideline by the Italian Association for the Study of the Liver (AISF)., guiderFrom=Dig Liver Dis. 2020 Jan 27., authorId=null, author=, summary=2020年1月,意大利肝病学会(AISF)发布了酒精性肝病管理指南,酒精使用障碍是西方国家最常见的肝损伤的原因,其疾病范围广泛,包括脂肪变性,脂肪性肝炎,肝纤维化,肝硬化和肝癌。本文主要内容涉及酒精性肝病的流行病学,病理生理学,临床表现,诊断以及治疗的相关内容,主要目的是针对酒精性肝病的临床管理提供指导建议。 , cover=, journalId=null, articlesId=null, associationId=487, associationName=意大利肝病学会, associationIntro=意大利肝病学会致力于肝病研究,官方杂志《Digestive and Liver Disease》, copyright=0, guiderPublishedTime=Mon Jan 27 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<P>2020年1月,意大利肝病学会(AISF)发布了酒精性肝病管理指南,酒精使用障碍是西方国家最常见的肝损伤的原因,其疾病范围广泛,包括脂肪变性,脂肪性肝炎,肝纤维化,肝硬化和肝癌。本文主要内容涉及酒精性肝病的流行病学,病理生理学,临床表现,诊断以及治疗的相关内容,主要目的是针对酒精性肝病的临床管理提供指导建议。 </P> <P> </P>拓展指南:<strong>与<font color=red>肝病</font>相关指南:</strong><br><ul><li><a href="//m.capotfarm.com/guideline/show_article.do?id=e330b1c001833558" title="2019 SIA意见书:晚期酒精性肝病和重症急性酒精性肝炎的管理" target=_blank>2019 SIA意见书:晚期酒精性肝病和重症急性酒精性肝炎的管理</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=90c371c00182a659" title="脂肪性肝病诊疗规范化的专家建议(2019 年修订版)" target=_blank>脂肪性肝病诊疗规范化的专家建议(2019 年修订版)</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=1afd21c001e96713" title="2019 EASL临床实践指南:职业性肝病" target=_blank>2019 EASL临床实践指南:职业性肝病</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=95d1e1c001e505ba" title="终末期肝病临床营养指南" target=_blank>终末期肝病临床营养指南</a></li> <li><a href="//m.capotfarm.com/guideline/show_article.do?id=35a7d1c001ea05d8" title="2019 澳大利亚共识声明:血液和恶性实体肿瘤患者免疫抑制期间乙肝病毒的管理" target=_blank>2019 澳大利亚共识声明:血液和恶性实体肿瘤患者免疫抑制期间乙肝病毒的管理</a></li> 更多信息请点击:<a href="//m.capotfarm.com/guideline/list.do?q=%E8%82%9D%E7%97%85" target=_blank>有关肝病更多指南</a></ul>, tagList=[TagDto(tagId=307, tagName=酒精性肝病)], categoryList=[CategoryDto(categoryId=4, categoryName=消化, tenant=100), CategoryDto(categoryId=22, categoryName=肝病, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=11376, appHits=376, showAppHits=4, pcHits=1912, showPcHits=10053, likes=36, shares=22, comments=9, approvalStatus=1, publishedTime=Sun Feb 09 00:55:04 CST 2020, publishedTimeString=2020-01-27, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sun Feb 09 00:55:04 CST 2020, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 21:56:26 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2020 AISF临床实践指南:酒精性肝病)])
2020 AISF临床实践指南:酒精性肝病
下载请点击:
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1077208, encodeId=b75010e72089e, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2cf5718950, createdName=1512, createdTime=Mon Dec 06 01:16:07 CST 2021, time=2021-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061490, encodeId=b384106149042, content=怎么才能看全文?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67801729593, createdName=mechelle_113, createdTime=Mon Oct 18 15:31:54 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007912, encodeId=e2dd100e912e6, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c52b2567759, createdName=12577ffdm54暂无昵称, createdTime=Sat Aug 14 21:15:28 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912475, encodeId=b0c49124e5ca, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5efb5417706, createdName=ms1000001402873749, createdTime=Thu Dec 31 09:33:32 CST 2020, time=2020-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893516, encodeId=642e893516da, content=👍👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201021/08e3fe49f39446959ac2dce9cf4ec13c/d1b5f73fd9bb42aeb8a27240bd10687e.jpg, createdBy=dc022393428, createdName=RIYI, createdTime=Wed Oct 21 14:12:33 CST 2020, time=2020-10-21, status=1, ipAttribution=)]
    2021-12-06 1512
  2. [GetPortalCommentsPageByObjectIdResponse(id=1077208, encodeId=b75010e72089e, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2cf5718950, createdName=1512, createdTime=Mon Dec 06 01:16:07 CST 2021, time=2021-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061490, encodeId=b384106149042, content=怎么才能看全文?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67801729593, createdName=mechelle_113, createdTime=Mon Oct 18 15:31:54 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007912, encodeId=e2dd100e912e6, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c52b2567759, createdName=12577ffdm54暂无昵称, createdTime=Sat Aug 14 21:15:28 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912475, encodeId=b0c49124e5ca, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5efb5417706, createdName=ms1000001402873749, createdTime=Thu Dec 31 09:33:32 CST 2020, time=2020-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893516, encodeId=642e893516da, content=👍👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201021/08e3fe49f39446959ac2dce9cf4ec13c/d1b5f73fd9bb42aeb8a27240bd10687e.jpg, createdBy=dc022393428, createdName=RIYI, createdTime=Wed Oct 21 14:12:33 CST 2020, time=2020-10-21, status=1, ipAttribution=)]
    2021-10-18 mechelle_113

    怎么才能看全文?

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1077208, encodeId=b75010e72089e, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2cf5718950, createdName=1512, createdTime=Mon Dec 06 01:16:07 CST 2021, time=2021-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061490, encodeId=b384106149042, content=怎么才能看全文?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67801729593, createdName=mechelle_113, createdTime=Mon Oct 18 15:31:54 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007912, encodeId=e2dd100e912e6, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c52b2567759, createdName=12577ffdm54暂无昵称, createdTime=Sat Aug 14 21:15:28 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912475, encodeId=b0c49124e5ca, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5efb5417706, createdName=ms1000001402873749, createdTime=Thu Dec 31 09:33:32 CST 2020, time=2020-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893516, encodeId=642e893516da, content=👍👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201021/08e3fe49f39446959ac2dce9cf4ec13c/d1b5f73fd9bb42aeb8a27240bd10687e.jpg, createdBy=dc022393428, createdName=RIYI, createdTime=Wed Oct 21 14:12:33 CST 2020, time=2020-10-21, status=1, ipAttribution=)]
    2021-08-14 12577ffdm54暂无昵称

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1077208, encodeId=b75010e72089e, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2cf5718950, createdName=1512, createdTime=Mon Dec 06 01:16:07 CST 2021, time=2021-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061490, encodeId=b384106149042, content=怎么才能看全文?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67801729593, createdName=mechelle_113, createdTime=Mon Oct 18 15:31:54 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007912, encodeId=e2dd100e912e6, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c52b2567759, createdName=12577ffdm54暂无昵称, createdTime=Sat Aug 14 21:15:28 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912475, encodeId=b0c49124e5ca, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5efb5417706, createdName=ms1000001402873749, createdTime=Thu Dec 31 09:33:32 CST 2020, time=2020-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893516, encodeId=642e893516da, content=👍👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201021/08e3fe49f39446959ac2dce9cf4ec13c/d1b5f73fd9bb42aeb8a27240bd10687e.jpg, createdBy=dc022393428, createdName=RIYI, createdTime=Wed Oct 21 14:12:33 CST 2020, time=2020-10-21, status=1, ipAttribution=)]
    2020-12-31 ms1000001402873749

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1077208, encodeId=b75010e72089e, content=<a href='/topic/show?id=23e3454e353' target=_blank style='color:#2F92EE;'>#学习#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45473, encryptionId=23e3454e353, topicName=学习)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c2cf5718950, createdName=1512, createdTime=Mon Dec 06 01:16:07 CST 2021, time=2021-12-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1061490, encodeId=b384106149042, content=怎么才能看全文?, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=67801729593, createdName=mechelle_113, createdTime=Mon Oct 18 15:31:54 CST 2021, time=2021-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1007912, encodeId=e2dd100e912e6, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c52b2567759, createdName=12577ffdm54暂无昵称, createdTime=Sat Aug 14 21:15:28 CST 2021, time=2021-08-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912475, encodeId=b0c49124e5ca, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=5efb5417706, createdName=ms1000001402873749, createdTime=Thu Dec 31 09:33:32 CST 2020, time=2020-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=893516, encodeId=642e893516da, content=👍👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=119, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201021/08e3fe49f39446959ac2dce9cf4ec13c/d1b5f73fd9bb42aeb8a27240bd10687e.jpg, createdBy=dc022393428, createdName=RIYI, createdTime=Wed Oct 21 14:12:33 CST 2020, time=2020-10-21, status=1, ipAttribution=)]
    2020-10-21 RIYI

    👍👍👍

    0

Baidu
map
Baidu
map
Baidu
map